Clinical Trials Logo

Clinical Trial Summary

Tacrolimus (FK506) is an immunosuppressive medication that promotes organ allograft survival. It has also been shown to enhance nerve regeneration and muscle reinnervation in animals but these properties have not previously been studied in patients. Moreover, currently there is no method in clinical use to speed the rate of recovery after nerve injury. The objective of this study is to explore the ability of tacrolimus to benefit the treatment of patients with peripheral nerve injury. To minimize the morbidity of tacrolimus therapy, its phase-specific effects on nerve regeneration and muscle reinnervation will be defined in the murine model to permit further limitation of the duration of therapy. The investigators hypothesize that treatment with tacrolimus after autogenous peripheral nerve reconstruction will accelerate nerve regeneration, reduce the period of denervation and improve muscle reinnervation and recovery in patients with peripheral nerve injury.

There are 2 specific aims:

1. Determine the safety and efficacy of tacrolimus following reconstructive nerve surgery in a double-blind placebo-controlled randomized pilot clinical trial of patients with severe nerve injuries of the extremities;

2. Correlate the quality of life outcome with assessment of functional recovery after surgical reconstruction of patients with severe peripheral nerve injuries of the extremities.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT00950391
Study type Interventional
Source Washington University School of Medicine
Contact
Status Withdrawn
Phase Phase 1/Phase 2
Start date August 2010
Completion date September 2015

See also
  Status Clinical Trial Phase
Recruiting NCT02359825 - Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function Phase 1
Not yet recruiting NCT02865317 - Cortical Effects of Peripheral Nerve Injury At Birth N/A
Recruiting NCT01554722 - Needle Nerve Contact in Ultrasound Guided Femoral Block N/A
Recruiting NCT06071936 - Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy Phase 3
Recruiting NCT06071988 - Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy Phase 3
Recruiting NCT05541250 - Safety and Efficacy of Autologous Human Schwann Cell (ahSC) Augmentation in Severe Peripheral Nerve Injury (PNI) Phase 1
Recruiting NCT06209632 - Mirror Therapy Combined With Contralaterally Controlled Functional Electrical Stimulation for Peripheral Nerve Injury N/A
Completed NCT01116362 - Comparing Primary With Secondary Repair of Based on Electrodiagnostic Assessment and Clinical Examination Phase 2
Withdrawn NCT04270019 - Polyethylene Glycol to Improve Sensation Following Digital Nerve Laceration Phase 1/Phase 2
Terminated NCT01088256 - Efficacy of Etoricoxib on Peripheral Hyperalgesia Phase 2
Completed NCT01302275 - Oxcarbazepine for the Treatment of Chronic Peripheral Neuropathic Pain Phase 4
Completed NCT02228928 - Study of Capsaicin Patch for the Management of Peripheral Neuropathic Pain Phase 1/Phase 2
Completed NCT00953277 - Study of Nerve Reconstruction Using AVANCE in Subjects Who Undergo Robotic Assisted Prostatectomy for Treatment of Prostate Cancer Phase 4
Not yet recruiting NCT06003166 - 4-AP Peripheral Nerve Crossover Trial Phase 3
Not yet recruiting NCT02666456 - The Influence of Sensory Phenotype on the Risk of Developing Neuropathic Pain N/A
Not yet recruiting NCT02352649 - Safety and Efficacy Study of Neovasculgen (Pl-VEGF165) Gene Therapy in Patients With Peripheral Nerve Injury Phase 1/Phase 2
Terminated NCT02034461 - Micro-Electrodes Implanted in a Human Nerve N/A
Completed NCT01596491 - Study of Possible Changes in QST After Application of Capsaicin on Patients With Peripheral Neuropathic Pain N/A
Recruiting NCT03147313 - Extracorporal Shock Wave Treatment to Improve Nerve Regeneration N/A